Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cook's permanent vena cava filter:

This article was originally published in Clinica

Executive Summary

Cook Medical has received US FDA 510(k) clearance to market its permanently implanted vena cava filter for capturing blood clots caused by medical conditions such as trauma and surgery before they can reach the lungs and cause a pulmonary embolism. The device, called Celect, was last year approved for permanent and retrieval indications in Canada, Australia and Europe. Trials are currently underway to study other aspects of the product, including its retrievability, said the Bloomington, Indiana firm. Celect employs a conical shape with a strut design that improves centering in the vessel and reduces in-growth, except at the desired end points.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049347

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel